1. S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDY. (23rd June 2022) Authors: Minard-Colin, V.; Buechner, J.; Locatelli, F.; Gonzalez Martinez, B.; Vormoor, B. J.; Cooper, S.; Krueger, J.; Napolitano, S.; Attarbaschi, A.; Baruchel, A.; Ghorashian, S.; Hermiston, M. L.; Hiramatsu, H.; Ifversen, M.; John, S.; Khaw, S. L.; O'Brien, T. A.; Phillips, C. L.; Diaz de Heredia, C.;... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S259: DUAL ANTIGEN TARGETING WITH CO-TRANSDUCED CD19/22 CAR T CELLS FOR RELAPSED/REFRACTORY ALL. (23rd June 2022) Authors: Ghorashian, S.; Lucchini, G.; Richardson, R.; Nguyen, K.; Terris, C.; Yeung, J.; Chu, J.; Williams, L.; Ko, K.; Walding, C.; Watts, K.; Inglott, S; Adams, S.; Gravett, E.; Gilmour, K.; Lal, A.; Kunaseelan, S.; Popova, B.; Lopes, A.; Ngai, Y. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗